| Barchart Demo Center |
$2.16
unch (unch)
as of May 17, 2024
as of May 17, 2024
| Last | 2.16 |
|---|---|
| Change | unch (unch) |
| Open | 2.21 |
| Prev. Close | 2.16 |
| Today's Range |
2.11
2.23
|
| 52wk Range |
1.54
16.94
|
| Volume | 16,700 |
| Avg Volume | 48,680 |
| Sector | SIC-2834 Pharmaceutical Preparations |
Perfomance Comparison
| Name | Today | 3-Month | 1-Year |
|---|---|---|---|
| TFFP | unch |
 -73.78% |
 -86.71% |
| DJIA |
 +0.34% |
 +3.13% |
+19.70% |
| S&P 500 |
+0.12% |
+2.83% |
+27.52% |
Key Statistics
| Annual EPS | -10.16 |
|---|---|
| Dividend Yield | 0.00% |
| P/E Ratio | N/A |
| Market Capitalization, $K | 4,690 |
| Weighted Alpha | -84.98 |
| Standard Deviation | unch |
| Profit Margin | -2,251.52% |
| Beta | 1.44 |
Growth Rates
| YTD | -69.23% | |||
| 1-Year | -86.06% | |||
| 3-Year | -99.18% |
Opinion
| Sell | Hold | Buy |
Recent Headlines
TFF Pharmaceuticals Provides Update on Tacrolimus
GlobeNewswire - Wed May 15, 06:00AM CDT
Patient Enrollment Has Accelerated with Now 10 Patients Enrolled in Phase 2 Trial 6 out of 6 Patients Who Completed the 12-Week Treatment Have Chosen to...(full story)
TFFP: 2.16 (unch)
TFF Pharmaceuticals Reports First Quarter Financial
GlobeNewswire - Tue May 14, 03:05PM CDT
Growing Body of Clinical Data from Ongoing Phase 2 Trial Suggests that Tacrolimus Inhalation Powder (TFF TAC) Could Represent an Important New Innovation...(full story)
TFFP: 2.16 (unch)
TFF Pharmaceuticals Announces Closing of Pricing of
GlobeNewswire - Wed May 01, 04:07PM CDT
FORT WORTH, Texas, May 01, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”), a clinical-stage...(full story)
TFFP: 2.16 (unch)
TFF Pharmaceuticals Announces Pricing of $4.8 Million
GlobeNewswire - Mon Apr 29, 07:00PM CDT
FORT WORTH, Texas, April 29, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”), a clinical-stage...(full story)
TFFP: 2.16 (unch)
TFF Pharmaceuticals Makes Available Phase 2 Data from
GlobeNewswire - Mon Apr 29, 09:00AM CDT
Data Now Available on Company Website Following 8-K Filing Data Demonstrate that Treatment with TFF TAC Prevents Lung Transplant Rejection at Only...(full story)
TFFP: 2.16 (unch)